M. Mahjoubi

1.4k total citations
24 papers, 1.1k citations indexed

About

M. Mahjoubi is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M. Mahjoubi has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M. Mahjoubi's work include Neutropenia and Cancer Infections (10 papers), Cancer therapeutics and mechanisms (9 papers) and Lung Cancer Research Studies (5 papers). M. Mahjoubi is often cited by papers focused on Neutropenia and Cancer Infections (10 papers), Cancer therapeutics and mechanisms (9 papers) and Lung Cancer Research Studies (5 papers). M. Mahjoubi collaborates with scholars based in France, Luxembourg and Spain. M. Mahjoubi's co-authors include Michel Ducreux, Jean‐Pierre Armand, Esteban Cvitkovic, G G Chabot, Patrice Herait, R. Bugat, D Abigerges, G. Catimel, M Forni and Marc Ychou and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

M. Mahjoubi

24 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Mahjoubi France 15 768 510 312 242 108 24 1.1k
Soh Saitoh Japan 12 853 1.1× 594 1.2× 265 0.8× 105 0.4× 64 0.6× 24 1.2k
W. Achterrath Germany 19 961 1.3× 443 0.9× 916 2.9× 576 2.4× 105 1.0× 53 1.7k
C.-M. Tsai Taiwan 15 629 0.8× 447 0.9× 484 1.6× 115 0.5× 56 0.5× 24 1.1k
Yoichiro Kakugawa Japan 21 625 0.8× 483 0.9× 309 1.0× 413 1.7× 64 0.6× 52 1.4k
A. Mathieu-Boué France 9 869 1.1× 522 1.0× 184 0.6× 89 0.4× 49 0.5× 14 1.1k
Sarita Dubey United States 22 692 0.9× 489 1.0× 792 2.5× 160 0.7× 169 1.6× 36 1.4k
P. A. Philip United States 21 800 1.0× 601 1.2× 436 1.4× 261 1.1× 42 0.4× 81 1.5k
Susumu Kawate Japan 15 336 0.4× 192 0.4× 213 0.7× 313 1.3× 146 1.4× 53 781
Moertel Cg United States 19 717 0.9× 156 0.3× 326 1.0× 300 1.2× 95 0.9× 53 1.1k
Jacqueline Duffour France 15 548 0.7× 146 0.3× 207 0.7× 151 0.6× 61 0.6× 23 806

Countries citing papers authored by M. Mahjoubi

Since Specialization
Citations

This map shows the geographic impact of M. Mahjoubi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Mahjoubi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Mahjoubi more than expected).

Fields of papers citing papers by M. Mahjoubi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Mahjoubi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Mahjoubi. The network helps show where M. Mahjoubi may publish in the future.

Co-authorship network of co-authors of M. Mahjoubi

This figure shows the co-authorship network connecting the top 25 collaborators of M. Mahjoubi. A scholar is included among the top collaborators of M. Mahjoubi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Mahjoubi. M. Mahjoubi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fallik, David, Marc Ychou, J H Jacob, et al.. (2003). Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancer. Annals of Oncology. 14(6). 856–863. 22 indexed citations
2.
Alexandre, Jérôme, Pascal Bleuzen, Jacques Bonneterre, et al.. (2000). Factors Predicting for Efficacy and Safety of Docetaxel in a Compassionate-Use Cohort of 825 Heavily Pretreated Advanced Breast Cancer Patients. Journal of Clinical Oncology. 18(3). 562–562. 70 indexed citations
3.
Bonneterre, Jacques, M. Spielman, Jean‐Paul Guastalla, et al.. (1999). Efficacy and safety of docetaxel (Taxotere™) in heavily pretreated advanced breast cancer patients. European Journal of Cancer. 35(10). 1431–1439. 47 indexed citations
4.
5.
Wasserman, Ernesto, Anne Myara, François Lokiec, et al.. (1997). Severe CPT-11 toxicity in patients with Gilbert's syndrome: Two case reports. Annals of Oncology. 8(10). 1049–1051. 146 indexed citations
6.
Chabot, G G, D Abigerges, G. Catimel, et al.. (1995). Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials. Annals of Oncology. 6(2). 141–151. 149 indexed citations
7.
Armand, Jean‐Pierre, Michel Ducreux, M. Mahjoubi, et al.. (1995). CPT-11 (Irinotecan) in the treatment of colorectal cancer. European Journal of Cancer. 31(7-8). 1283–1287. 97 indexed citations
8.
Rixe, Olivier, A. Benhammouda, C Farabos, et al.. (1995). 955 A phase I study of concomitant CPT-11 (C) and 5FU (F) combination: Preliminary results. European Journal of Cancer. 31. S198–S199. 3 indexed citations
9.
Pujol, Jean-Louis, Thierry Le Chevalier, Jean‐Yves Douillard, et al.. (1995). 92 CPT 11 (Irinotecan) in pretreated small cell lung cancer (SCLC): A phase II study in patients progressing after a first response (preliminary results). European Journal of Cancer. 31. S21–S21. 5 indexed citations
10.
Catimel, G., G G Chabot, Jean‐Paul Guastalla, et al.. (1995). Phase I and pharmacokinetic study of irinotecan (CPT-11) administered daily for three consecutive days every three weeks in patients with advanced solid tumors. Annals of Oncology. 6(2). 133–140. 94 indexed citations
11.
Rougier, P, P Lasser, Michel Ducreux, et al.. (1994). Gastric Cancer: Preoperative chemotherapy of locally advanced gastric cancer. Annals of Oncology. 5. S59–S68. 40 indexed citations
12.
Rougier, P, M. Mahjoubi, P Lasser, et al.. (1994). Neoadjuvant chemotherapy in locally advanced gastric carcinoma—a phase II trial with combined continuous intravenous 5-fluorouracil and bolus cisplatinum. European Journal of Cancer. 30(9). 1269–1275. 56 indexed citations
13.
Kattan, Joseph, M. Durand, Jean‐Pierre Droz, et al.. (1994). Phase I Study of Retelliptine Dihydrochloride (SR 95325 B) Using a Single Two-Hour Intravenous Infusion Schedule. American Journal of Clinical Oncology. 17(3). 242–245. 14 indexed citations
14.
Ducreux, Michel, M. Mahjoubi, Jean‐Pierre Pignon, et al.. (1994). Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysis. European Journal of Cancer. 30(9). 1263–1269. 91 indexed citations
15.
Rougier, Philippe, J. J. Zarba, Michel Ducreux, et al.. (1993). Phase II study of cisplatin and 120-hour continuous infusion of 5-fluorouracil in patients with advanced pancreatic adenocarcinoma. Annals of Oncology. 4(4). 333–336. 53 indexed citations
16.
Kattan, Joseph, M. Mahjoubi, Jean‐Pierre Droz, et al.. (1993). High failure rate of carboplatin-etoposide combination in good risk non-seminomatous germ cell tumours. European Journal of Cancer. 29(11). 1504–1509. 8 indexed citations
17.
Mahjoubi, M., et al.. (1992). Phase II trial of pirarubicin in the treatment of advanced bladder cancer. Investigational New Drugs. 10(4). 317–321. 5 indexed citations
18.
Boutan-Laroze, Arnaud, M. Mahjoubi, Jean‐Pierre Droz, et al.. (1991). M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced carcinoma of the bladder. European Journal of Cancer and Clinical Oncology. 27(12). 1690–1694. 57 indexed citations
19.
Mahjoubi, M., et al.. (1990). Phase II Trial of Ifosfamide in the Treatment of Metastatic Hormone-Refractory Patients with Prostatic Cancer. Cancer Investigation. 8(5). 477–481. 11 indexed citations
20.
Lasser, P, Philippe Rougier, M. Mahjoubi, et al.. (1989). [Neoadjuvant chemotherapy in locally advanced gastric adenocarcinoma. Preliminary results].. PubMed. 115(6). 365–72. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Soh Saitoh Breakdown of academic impact, for papers by W. Achterrath Breakdown of academic impact, for papers by C.-M. Tsai Breakdown of academic impact, for papers by Yoichiro Kakugawa Breakdown of academic impact, for papers by A. Mathieu-Boué Breakdown of academic impact, for papers by Sarita Dubey Breakdown of academic impact, for papers by P. A. Philip Breakdown of academic impact, for papers by Susumu Kawate Breakdown of academic impact, for papers by Moertel Cg Breakdown of academic impact, for papers by Jacqueline Duffour
Rankless by CCL
2026